Treatment.com AI Grants Stock Option and RSUs

Core Points - Treatment.com AI Inc. has granted 799,920 restricted share units (RSUs) and 162,480 stock options to its officers, directors, consultants, and employees [1][2] - The stock options are exercisable at C$0.50 per share for three years and vest over one year, while 700,000 RSUs are valid for five years and 99,920 RSUs for three years, all vesting over one year [2] - The company has engaged FN Media Group for a one-day news/media marketing campaign for USD$4,295 during the week of June 23 - June 27, 2025 [3][4] Company Overview - Treatment.com AI utilizes artificial intelligence and clinical best practices to enhance the healthcare sector, addressing inefficiencies and challenges [5] - The company has developed the Global Library of Medicine (GLM), a comprehensive AI engine that provides over 10,000 expert medical reviews, supporting healthcare professionals with clinical information, recommended tests, and billing codes [5] - The GLM aims to reduce administrative burdens for healthcare professionals, allowing more time for patient interactions and improving the consistency of patient support [5]